Clearside Biomedical, Inc. ã¯ãã€ãªå»è¬åäŒç€Ÿã§ãé節ãªçŒçŸæ£ãæã€äººã
ã®èŠåãå埩ããç¶æããæ²»çæ³ã®éçºãšæäŸã«åãçµãã§ããŸããå瀟ã®è£œåã«ã¯ã第 1/2a çžèšåºè©Šéšäžã®è絡èäžæ³šå°çšã¢ãã·ãããã§ãã CLS-AX ããããŸãããŸãããããŠèçã«äŒŽãé»ææµ®è
«ãç³å°¿ç
æ§é»ææµ®è
«ãç¶²èéèéå¡çã«äŒŽãé»ææµ®è
«ã®æ²»çãç®çãšãããããªã¢ã ã·ããã³ã¢ã»ãããè絡èäžæ³šå°çšæžæ¿æ¶²ã§ãã XIPERE ãéçºããŠããŸããå瀟㯠2011 幎ã«èšç«ããããžã§ãŒãžã¢å·ã¢ã«ãã¡ã¬ãã¿ã«æ¬ç€Ÿã眮ããŠããŸãã